These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 5339995)

  • 41. [Monoamine oxidase inhibition and hypertensive paroxysms: importance of the method of administration].
    Sicuteri F; Del Bianco PL; Del Bene E
    Boll Soc Ital Biol Sper; 1966 Sep; 42(17):1163-6. PubMed ID: 5971368
    [No Abstract]   [Full Text] [Related]  

  • 42. An investigation into the sedative properties of salicylamide.
    Jourdan MH
    Guys Hosp Rep; 1969; 118(4):543-8. PubMed ID: 4917344
    [No Abstract]   [Full Text] [Related]  

  • 43. [Difficulties of evaluation of the results of drug treatment of schizophrenia].
    Welbel L
    Psychiatr Pol; 1980; 14(1):51-7. PubMed ID: 6102774
    [No Abstract]   [Full Text] [Related]  

  • 44. [Phenelzine in anergic schizophrenia (clinical trials)].
    Di Genio R; Pellicanò C
    Osp Psichiatr; 1968; 36(3):457-64. PubMed ID: 5733535
    [No Abstract]   [Full Text] [Related]  

  • 45. Reversal of reserpine-induced catalepsy by selective D1 and D2 dopamine agonists.
    Hubbard CA; Trugman JM
    Mov Disord; 1993 Oct; 8(4):473-8. PubMed ID: 7901761
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hemodynamic effects of naloxone during clonidine treatment of patients with essential hypertension].
    Varga K; Kapocsi J; Juhász I; Kunos G; Farsang C
    Orv Hetil; 1983 Apr; 124(17):991-5. PubMed ID: 6346221
    [No Abstract]   [Full Text] [Related]  

  • 47. Antagonism of beta-phenylethylamine derivatives and serotonin blocking drugs upon serotonin, tryptamine and reserpine behavioral depression in mice.
    Saavedra JM; Fischer E
    Arzneimittelforschung; 1970 Jul; 20(7):952-7. PubMed ID: 5536068
    [No Abstract]   [Full Text] [Related]  

  • 48. Clinical trial of triperidol.
    Chien C; DiMascio A; Ewalt JR
    Curr Ther Res Clin Exp; 1967 Nov; 9(11):544-50. PubMed ID: 4965502
    [No Abstract]   [Full Text] [Related]  

  • 49. Partial inhibition of reverse tolerance by a high dose of ritanserin or low dose of haloperidol in methamphetamine-sensitized rat.
    Tanaka T; Ishigooka J; Watanabe S; Nagata E; Miura S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1998 Feb; 18(1):1-7. PubMed ID: 9592805
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Comparative test of antihypertensive effects of N-diethylaminoethyl reserpine (bietaserpine) and other similar drugs].
    Murakami M; Sekimoto H; Nakat I; Iwaki N; Nakai T
    Saishin Igaku; 1971 Jan; 26(1):145-53. PubMed ID: 5539259
    [No Abstract]   [Full Text] [Related]  

  • 51. Effects of 25 mT static magnetic field on blood pressure in reserpine-induced hypotensive Wistar-Kyoto rats.
    Okano H; Masuda H; Ohkubo C
    Bioelectromagnetics; 2005 Jan; 26(1):36-48. PubMed ID: 15605399
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Duration of antidepressant trials: clinical and research implications.
    Donovan SJ; Quitkin FM; Stewart JW; Ocepek-Welikson K; Harrison W; McGrath PJ; Nunes EV; Wager S; Tricamo E
    J Clin Psychopharmacol; 1994 Feb; 14(1):64-6. PubMed ID: 8151005
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pharmacological properties of new antidepressive agent azaphen].
    Mashkovskiĭ MD; Polezhaeva AI
    Farmakol Toksikol; 1969; 32(6):656-62. PubMed ID: 5381594
    [No Abstract]   [Full Text] [Related]  

  • 54. Treatment with subthreshold doses of caffeine plus trihexyphenidyl fully restores locomotion and exploratory activity in reserpinized rats.
    Moo-Puc RE; Villanueva-Toledo J; Arankowsky-Sandoval G; Alvarez-Cervera F; Góngora-Alfaro JL
    Neurosci Lett; 2004 Sep; 367(3):327-31. PubMed ID: 15337259
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acetylator status and response to phenelzine.
    Tyrer P; Gardner M
    Lancet; 1978 Nov; 2(8097):994-5. PubMed ID: 82019
    [No Abstract]   [Full Text] [Related]  

  • 56. [Effects of a combination of gamma-aminobutyric acid and reserpine on the intellectual activity and affectivity of university students during exams].
    Valente LC; Vieira FJ
    Hospital (Rio J); 1969 Sep; 76(3):1137-42. PubMed ID: 4929570
    [No Abstract]   [Full Text] [Related]  

  • 57. Changes in urine volume and diurnal rhythm caused by reserpine treatment of schizophrenic patients.
    Randrup A; Munkvad I
    Br J Psychiatry; 1966 Feb; 112(483):173-6. PubMed ID: 5908270
    [No Abstract]   [Full Text] [Related]  

  • 58. Drug interactions between herbal and prescription medicines.
    Williamson EM
    Drug Saf; 2003; 26(15):1075-92. PubMed ID: 14640772
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical observations on reserpine reversal after prolonged MAO inhibition.
    Esser AH
    Psychiatr Neurol Neurochir; 1967; 70(1):59-63. PubMed ID: 5339995
    [No Abstract]   [Full Text] [Related]  

  • 60. TWO-YEAR FOLLOW-UP STUDY OF PROTEIN-BOUND IODINE ELEVATION IN PATIENTS RECEIVING PERPHENAZINE.
    CRANSWICK EH; COOPER TB; SIMPSON GM
    Am J Psychiatry; 1965 Sep; 122():300-5. PubMed ID: 14327471
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.